Dr. Scott Elder Bagenstose, MD

Dr. Bagenstose practices at Ohio ENT and Allergy Physicians in Columbus, Ohio.

Dr. Bagenstose's NPI, 1326000472, was assigned on April 4, 2006. Dr. Bagenstose graduated from University Of Cincinnati College Of Medicine in 1999. Dr. Bagenstose's Ohio license number on file is 35081229B.

Dr. Bagenstose's primary practice is Ohio ENT and Allergy Physicians, at 974 Bethel Rd, Columbus, OH 43214 in Franklin County. The practice phone is (614) 273-2230.

Dr. Bagenstose's primary practice is Ohio ENT and Allergy Physicians in Columbus, Ohio. Dr. Bagenstose is also affiliated with Ohio State University Hospital. The medical group on file is Ohio ENT & Allergy Physicians. Dmand AI also links Dr. Bagenstose to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bagenstose practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Bagenstose's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Bagenstose is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Bagenstose's licenses on file in 2 states: Ohio and Michigan.

Dmand AI lists asthma, chronic nasal allergies, chronic sinusitis and hives among the conditions Dr. Bagenstose treats.

CMS data shows 15,636 Medicare services from Dr. Bagenstose across 11 procedure codes in 2024, for 554 Medicare patients. Medicare paid $111,133 for them. Every service was in an office.

CMS counts 554 Medicare patients who saw Dr. Bagenstose in 2024. The largest group is 65 to 74, with 340 patients. 72% of them have high cholesterol, and 66% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bagenstose's median patient age at 49, with 64% women.

In 2024, Dr. Bagenstose wrote 6,978 Medicare Part D claims for 943 patients. 81% of them were for generic drugs. CMS names the drug for 6,798 of them, across 65 drugs with 11 or more claims each, at $921,795 in total drug cost. In 2023, CMS named 5,816 claims across 55 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bagenstose for performance year 2024, reported as part of a group. Dr. Bagenstose accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bagenstose as offering telehealth.

Dmand AI links 3 papers to Dr. Bagenstose. Dr. Bagenstose's most frequent co-author is Jonathan Bernstein, MD.

CMS Open Payments shows 1,152 general payments to Dr. Bagenstose from 41 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Sanofi and Genzyme US Companies paid the most, $6,629.

Dr. Bagenstose graduated from University Of Cincinnati College Of Medicine in 1999.

Dr. Bagenstose is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Molina. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.